Nuo Therapeutics, Inc.
AURX
$1.50
-$0.021-1.38%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.36M | -2.32M | -2.48M | -2.69M | -3.02M |
| Total Depreciation and Amortization | 101.40K | 96.30K | 94.90K | 100.80K | 106.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 52.90K | 32.50K | 137.70K | 214.40K | 216.00K |
| Change in Net Operating Assets | 539.50K | -36.70K | -164.90K | -342.40K | -233.00K |
| Cash from Operations | -1.67M | -2.23M | -2.41M | -2.72M | -2.93M |
| Capital Expenditure | -384.90K | -155.00K | -155.00K | -6.00K | -1.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -384.90K | -155.00K | -155.00K | -6.00K | -1.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.74M | 1.74M | 2.61M | 2.80M | 2.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.74M | 1.74M | 2.61M | 2.80M | 2.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -310.60K | -644.90K | 46.30K | 73.70K | -939.00K |